Old Web
English
Sign In
Acemap
>
Paper
>
Crizotinib (Xalkori): The First‐in‐Class ALK/ROS Inhibitor for Non‐small Cell Lung Cancer
Crizotinib (Xalkori): The First‐in‐Class ALK/ROS Inhibitor for Non‐small Cell Lung Cancer
2015
Pei-Pei Kung
Ricky Anthony Jones
Paul G. Richardson
Keywords:
Cell
c-Met inhibitor
Lung cancer
Cancer research
Crizotinib
Biology
Anaplastic lymphoma kinase
non small cell
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
59
References
0
Citations
NaN
KQI
[]